FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904001054> ?p ?o ?g. }

• W2904001054 endingPage "44" @default.
• W2904001054 startingPage "31" @default.
• W2904001054 abstract "Success of 3D tissue substitutes in clinical applications depends on the presence of vascular networks in their structure. Accordingly, research in tissue engineering is focused on the stimulation of angiogenesis or generation of a vascular network in the scaffolds prior to implantation. A novel, xeno-free, collagen/hyaluronic acid-based poly(l-lactide-co-ε-caprolactone) (PLC/COL/HA) (20/9.5/0.5 w/w/w) microfibrous scaffold was produced by electrospinning. Collagen types I and III, and hyaluronic acid were isolated from human umbilical cords and blended with the GMP grade PLC. When compared with PLC scaffolds the PLC/COL/HA had higher water uptake capacity (103% vs 66%) which may have contributed to the decrease in its Young's Modulus (from 1.31 to 0.89 MPa). The PLC/COL/HA better supported adipose tissue-derived mesenchymal stem cell (AT MSC) adhesion; within 24 h the cell number on the PLC/COL/HA scaffolds was 3 fold higher. Co-culture of human umbilical vein endothelial cells and AT MSCs induced capillary formation on both scaffold types, but the PLC/COL/HA led to formation of interconnected vessels whose total length was 1.6 fold of the total vessel length on PLC. Clinical use of this scaffold would eliminate the immune response triggered by xenogeneic collagen and transmission of animal-borne diseases while promoting a better vascular network formation." @default.
• W2904001054 created "2018-12-22" @default.
• W2904001054 creator A5004346273 @default.
• W2904001054 creator A5010487644 @default.
• W2904001054 creator A5016941067 @default.
• W2904001054 creator A5041796947 @default.
• W2904001054 creator A5086121251 @default.
• W2904001054 creator A5090975616 @default.
• W2904001054 date "2019-04-01" @default.
• W2904001054 modified "2023-10-14" @default.
• W2904001054 title "Microfibrous scaffolds from poly(l-lactide-co-ε-caprolactone) blended with xeno-free collagen/hyaluronic acid for improvement of vascularization in tissue engineering applications" @default.
• W2904001054 cites W1483526410 @default.
• W2904001054 cites W1507674747 @default.
• W2904001054 cites W16773616 @default.
• W2904001054 cites W1965074521 @default.
• W2904001054 cites W1970677655 @default.
• W2904001054 cites W1971850571 @default.
• W2904001054 cites W1974638778 @default.
• W2904001054 cites W1975854345 @default.
• W2904001054 cites W1976117064 @default.
• W2904001054 cites W1983341185 @default.
• W2904001054 cites W1984294186 @default.
• W2904001054 cites W2001868884 @default.
• W2904001054 cites W2004611121 @default.
• W2904001054 cites W2004768960 @default.
• W2904001054 cites W2014446724 @default.
• W2904001054 cites W2016305198 @default.
• W2904001054 cites W2021270871 @default.
• W2904001054 cites W2025286668 @default.
• W2904001054 cites W2025291066 @default.
• W2904001054 cites W2025668847 @default.
• W2904001054 cites W2027644637 @default.
• W2904001054 cites W2029259783 @default.
• W2904001054 cites W2034479167 @default.
• W2904001054 cites W2034642786 @default.
• W2904001054 cites W2039338570 @default.
• W2904001054 cites W2039692967 @default.
• W2904001054 cites W2046115922 @default.
• W2904001054 cites W2047144232 @default.
• W2904001054 cites W2079033940 @default.
• W2904001054 cites W2081958397 @default.
• W2904001054 cites W2082602763 @default.
• W2904001054 cites W2084610464 @default.
• W2904001054 cites W2085269784 @default.
• W2904001054 cites W2100994660 @default.
• W2904001054 cites W2102730475 @default.
• W2904001054 cites W2108933906 @default.
• W2904001054 cites W2116146575 @default.
• W2904001054 cites W2120099071 @default.
• W2904001054 cites W2124288159 @default.
• W2904001054 cites W2135516291 @default.
• W2904001054 cites W2137612350 @default.
• W2904001054 cites W2153099809 @default.
• W2904001054 cites W2158766228 @default.
• W2904001054 cites W2159185781 @default.
• W2904001054 cites W2167616644 @default.
• W2904001054 cites W2169931542 @default.
• W2904001054 cites W2228199987 @default.
• W2904001054 cites W2400798143 @default.
• W2904001054 cites W2551378425 @default.
• W2904001054 cites W2560241506 @default.
• W2904001054 cites W2562841667 @default.
• W2904001054 cites W2581349431 @default.
• W2904001054 cites W2590195315 @default.
• W2904001054 cites W2592198079 @default.
• W2904001054 cites W2596787754 @default.
• W2904001054 cites W2602313230 @default.
• W2904001054 cites W2615147484 @default.
• W2904001054 cites W2621665612 @default.
• W2904001054 cites W2624508252 @default.
• W2904001054 cites W2626765272 @default.
• W2904001054 cites W2727650765 @default.
• W2904001054 cites W2755274340 @default.
• W2904001054 cites W2762882831 @default.
• W2904001054 cites W2780991487 @default.
• W2904001054 cites W2793758510 @default.
• W2904001054 cites W2883799062 @default.
• W2904001054 cites W748778482 @default.
• W2904001054 doi "https://doi.org/10.1016/j.msec.2018.12.011" @default.
• W2904001054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30678916" @default.
• W2904001054 hasPublicationYear "2019" @default.
• W2904001054 type Work @default.
• W2904001054 sameAs 2904001054 @default.
• W2904001054 citedByCount "52" @default.
• W2904001054 countsByYear W29040010542019 @default.
• W2904001054 countsByYear W29040010542020 @default.
• W2904001054 countsByYear W29040010542021 @default.
• W2904001054 countsByYear W29040010542022 @default.
• W2904001054 countsByYear W29040010542023 @default.
• W2904001054 crossrefType "journal-article" @default.
• W2904001054 hasAuthorship W2904001054A5004346273 @default.
• W2904001054 hasAuthorship W2904001054A5010487644 @default.
• W2904001054 hasAuthorship W2904001054A5016941067 @default.
• W2904001054 hasAuthorship W2904001054A5041796947 @default.
• W2904001054 hasAuthorship W2904001054A5086121251 @default.
• W2904001054 hasAuthorship W2904001054A5090975616 @default.
• W2904001054 hasConcept C105702510 @default.
• W2904001054 hasConcept C126322002 @default.

• next